Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386929172> ?p ?o ?g. }
- W4386929172 endingPage "1026" @default.
- W4386929172 startingPage "1026" @default.
- W4386929172 abstract "Changes in the maternal metabolome, and specifically the maternal lipidome, that occur during pregnancy are relatively unknown. The objective of this investigation was to evaluate the effects of pregnancy on sphingolipid levels using metabolomics analysis followed by confirmational, targeted quantitative analysis. We focused on three subclasses of sphingolipids: ceramides, sphingomyelins, and sphingosines. Forty-seven pregnant women aged 18 to 50 years old participated in this study. Blood samples were collected on two study days for metabolomics analysis. The pregnancy samples were collected between 25 and 28 weeks of gestation and the postpartum study day samples were collected ≥3 months postpartum. Each participant served as their own control. These samples were analyzed using a Ultra-performance liquid chromatography/mass spectroscopy/mass spectroscopy (UPLC/MS/MS) assay that yielded semi-quantitative peak area values that were used to compare sphingolipid levels between pregnancy and postpartum. Following this lipidomic analysis, quantitative LC/MS/MS targeted/confirmatory analysis was performed on the same study samples. In the metabolomic analysis, 43 sphingolipid metabolites were identified and their levels were assessed using relative peak area values. These profiled sphingolipids fell into three categories: ceramides, sphingomyelins, and sphingosines. Of the 43 analytes measured, 35 were significantly different during pregnancy (p < 0.05) (including seven ceramides, 26 sphingomyelins, and two sphingosines) and 32 were significantly higher during pregnancy compared to postpartum. Following metabolomics, a separate quantitative analysis was performed and yielded quantified concentration values for 23 different sphingolipids, four of which were also detected in the metabolomics study. Quantitative analysis supported the metabolomics results with 17 of the 23 analytes measured found to be significantly different during pregnancy including 11 ceramides, four sphingomyelins, and two sphingosines. Fourteen of these were significantly higher during pregnancy. Our data suggest an overall increase in plasma sphingolipid concentrations with possible implications in endothelial function, gestational diabetes mellitus (GDM), intrahepatic cholestasis of pregnancy, and fetal development. This study provides evidence for alterations in maternal sphingolipid metabolism during pregnancy." @default.
- W4386929172 created "2023-09-22" @default.
- W4386929172 creator A5002993061 @default.
- W4386929172 creator A5007205852 @default.
- W4386929172 creator A5008158265 @default.
- W4386929172 creator A5029408137 @default.
- W4386929172 creator A5036636635 @default.
- W4386929172 creator A5069127804 @default.
- W4386929172 creator A5071708181 @default.
- W4386929172 creator A5076233159 @default.
- W4386929172 creator A5080964131 @default.
- W4386929172 date "2023-09-21" @default.
- W4386929172 modified "2023-10-17" @default.
- W4386929172 title "Effects of Pregnancy on Plasma Sphingolipids Using a Metabolomic and Quantitative Analysis Approach" @default.
- W4386929172 cites W117546959 @default.
- W4386929172 cites W1256777839 @default.
- W4386929172 cites W1971062375 @default.
- W4386929172 cites W2001255651 @default.
- W4386929172 cites W2090721334 @default.
- W4386929172 cites W2138137064 @default.
- W4386929172 cites W2141091417 @default.
- W4386929172 cites W2403198051 @default.
- W4386929172 cites W2415858857 @default.
- W4386929172 cites W2604951002 @default.
- W4386929172 cites W2607572215 @default.
- W4386929172 cites W2618617063 @default.
- W4386929172 cites W2756856378 @default.
- W4386929172 cites W2794877394 @default.
- W4386929172 cites W2981696980 @default.
- W4386929172 cites W2987075106 @default.
- W4386929172 cites W3133950152 @default.
- W4386929172 cites W3157628923 @default.
- W4386929172 cites W3161853641 @default.
- W4386929172 cites W3214314398 @default.
- W4386929172 cites W4200384759 @default.
- W4386929172 cites W4206004999 @default.
- W4386929172 cites W4245409061 @default.
- W4386929172 cites W4309174101 @default.
- W4386929172 cites W4315498267 @default.
- W4386929172 cites W4319598499 @default.
- W4386929172 cites W4361274910 @default.
- W4386929172 doi "https://doi.org/10.3390/metabo13091026" @default.
- W4386929172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37755306" @default.
- W4386929172 hasPublicationYear "2023" @default.
- W4386929172 type Work @default.
- W4386929172 citedByCount "0" @default.
- W4386929172 crossrefType "journal-article" @default.
- W4386929172 hasAuthorship W4386929172A5002993061 @default.
- W4386929172 hasAuthorship W4386929172A5007205852 @default.
- W4386929172 hasAuthorship W4386929172A5008158265 @default.
- W4386929172 hasAuthorship W4386929172A5029408137 @default.
- W4386929172 hasAuthorship W4386929172A5036636635 @default.
- W4386929172 hasAuthorship W4386929172A5069127804 @default.
- W4386929172 hasAuthorship W4386929172A5071708181 @default.
- W4386929172 hasAuthorship W4386929172A5076233159 @default.
- W4386929172 hasAuthorship W4386929172A5080964131 @default.
- W4386929172 hasBestOaLocation W43869291721 @default.
- W4386929172 hasConcept C126322002 @default.
- W4386929172 hasConcept C135870905 @default.
- W4386929172 hasConcept C185592680 @default.
- W4386929172 hasConcept C21565614 @default.
- W4386929172 hasConcept C2777477808 @default.
- W4386929172 hasConcept C2778163477 @default.
- W4386929172 hasConcept C2779234561 @default.
- W4386929172 hasConcept C2780241833 @default.
- W4386929172 hasConcept C42407357 @default.
- W4386929172 hasConcept C43617362 @default.
- W4386929172 hasConcept C54355233 @default.
- W4386929172 hasConcept C55493867 @default.
- W4386929172 hasConcept C58017582 @default.
- W4386929172 hasConcept C61322309 @default.
- W4386929172 hasConcept C61705674 @default.
- W4386929172 hasConcept C71924100 @default.
- W4386929172 hasConcept C86803240 @default.
- W4386929172 hasConcept C95986675 @default.
- W4386929172 hasConceptScore W4386929172C126322002 @default.
- W4386929172 hasConceptScore W4386929172C135870905 @default.
- W4386929172 hasConceptScore W4386929172C185592680 @default.
- W4386929172 hasConceptScore W4386929172C21565614 @default.
- W4386929172 hasConceptScore W4386929172C2777477808 @default.
- W4386929172 hasConceptScore W4386929172C2778163477 @default.
- W4386929172 hasConceptScore W4386929172C2779234561 @default.
- W4386929172 hasConceptScore W4386929172C2780241833 @default.
- W4386929172 hasConceptScore W4386929172C42407357 @default.
- W4386929172 hasConceptScore W4386929172C43617362 @default.
- W4386929172 hasConceptScore W4386929172C54355233 @default.
- W4386929172 hasConceptScore W4386929172C55493867 @default.
- W4386929172 hasConceptScore W4386929172C58017582 @default.
- W4386929172 hasConceptScore W4386929172C61322309 @default.
- W4386929172 hasConceptScore W4386929172C61705674 @default.
- W4386929172 hasConceptScore W4386929172C71924100 @default.
- W4386929172 hasConceptScore W4386929172C86803240 @default.
- W4386929172 hasConceptScore W4386929172C95986675 @default.
- W4386929172 hasFunder F4320337354 @default.
- W4386929172 hasIssue "9" @default.
- W4386929172 hasLocation W43869291721 @default.
- W4386929172 hasLocation W43869291722 @default.
- W4386929172 hasOpenAccess W4386929172 @default.